Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for its membrane localization in human hepatocellular carcinoma

FEBS Letters

Volumn 581, Issue 5, 2007, Pages 989-994

  Sibold, Sonja ^a   Roh, Vincent ^a   Keogh, Adrian ^a   Studer, Peter ^a   Tiffon, Céline ^a   Angst, Eliane ^a   Vorburger, Stephan A ^a   Weimann, Rosemarie ^a   Candinas, Daniel ^a   Stroka, Deborah ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Carcinoma, hepatocellular; HIF 1; Hypoxia; N myc downstream regulated gene 1

Indexed keywords

CELL PROTEIN; PROTEIN NDRG1; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL HYPOXIA; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TUMOR XENOGRAFT;

AMINO ACID SEQUENCE; ANIMALS; ANOXIA; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; CYTOPLASM; GENE EXPRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; MALE; MICE; MICE, NUDE; MOLECULAR SEQUENCE DATA; NEOPLASM TRANSPLANTATION; PROTEIN STRUCTURE, TERTIARY; TRANSPLANTATION, HETEROLOGOUS;

EID: 33847097342     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.01.080     Document Type: Article

References (25)

1. Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., and Commes T. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim. Biophys. Acta 1450 (1999) 364-373
2. Kokame K., Kato H., and Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. J. Biol. Chem. 271 (1996) 29659-29665
3. van Belzen N., et al. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab. Invest. 77 (1997) 85-92
4. Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A., and Lee S.W. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res. 58 (1998) 4439-4444
5. Bandyopadhyay S., et al. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res. 63 (2003) 1731-1736
6. Bandyopadhyay S., et al. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23 (2004) 5675-5681
7. Guan R.J., Ford H.L., Fu Y., Li Y., Shaw L.M., and Pardee A.B. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res. 60 (2000) 749-755
8. Maruyama Y., et al. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res. 66 (2006) 6233-6242
9. Cangul H., Salnikow K., Yee H., Zagzag D., Commes T., and Costa M. Enhanced expression of a novel protein in human cancer cells: a potential aid to cancer diagnosis. Cell Biol. Toxicol. 18 (2002) 87-96
10. Park H., Adams M.A., Lachat P., Bosman F., Pang S.C., and Graham C.H. Hypoxia induces the expression of a 43-kDa protein (PROXY-1) in normal and malignant cells. Biochem. Biophys. Res. Commun. 276 (2000) 321-328
11. Salnikow K., Blagosklonny M.V., Ryan H., Johnson R., and Costa M. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res. 60 (2000) 38-41
12. Wang G.L., and Semenza G.L. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268 (1993) 21513-21518
13. Maxwell P.H., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
14. Ohh M., and Kaelin Jr. W.G. The von Hippel-Lindau tumour suppressor protein: new perspectives. Mol. Med. Today 5 (1999) 257-263
15. Schofield C.J., and Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5 (2004) 343-354
16. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
17. Vogelstein B., and Kinzler K.W. Cancer genes and the pathways they control. Nat. Med. 10 (2004) 789-799
18. Kim K.R., Moon H.E., and Kim K.W. Hypoxia-induced angiogenesis in human hepatocellular carcinoma. J. Mol. Med. 80 (2002) 703-714
19. Stroka D.M., Burkhardt T., Desbaillets I., Wenger R.H., Neil D.A.H., Bauer C., Gassmann M., and Candinas D. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. Faseb J. 15 (2001) 2445-2453
20. Murray J.T., et al. Exploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3. Biochem. J. 384 (2004) 477-488
21. Cummins E.P., and Taylor C.T. Hypoxia-responsive transcription factors. Pflugers Arch. 450 (2005) 363-371
22. Yasuda S., et al. Hexokinase II and VEGF expression in liver tumors: correlation with hypoxia-inducible factor 1 alpha and its significance. J. Hepatol. 40 (2004) 117-123
23. Huang G.W., Yang L.Y., and Lu W.Q. Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in hepatocellular carcinoma: impact on neovascularization and survival. World J. Gastroenterol. 11 (2005) 1705-1708
24. Cangul H., Salnikow K., Yee H., Zagzag D., Commes T., and Costa M. Enhanced overexpression of an HIF-1/hypoxia-related protein in cancer cells. Environ. Health Perspect. 110 Suppl. 5 (2002) 783-788
25. Mottet D., Dumont V., Deccache Y., Demazy C., Ninane N., Raes M., and Michiels C. Regulation of hypoxia-inducible factor-1alpha protein level during hypoxic conditions by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta pathway in HepG2 cells. J. Biol. Chem. 278 (2003) 31277-31285